Tirzepatide is a medication used to manage type 2 diabetes and promote weight loss. It is a dual GLP-1 and GIP receptor agonist, which means it mimics the effects of two natural hormones that help regulate blood sugar levels and appetite.

For weight loss, tirzepatide is typically administered as a weekly injection. It helps reduce appetite, delay gastric emptying, and increase insulin release, which can lead to significant weight loss when combined with a reduced-calorie diet and increased physical activity.

In addition to its weight loss benefits, tirzepatide has shown potential in improving cardiovascular health and reducing the risk of heart failure in patients with obesity-related heart failure with preserved ejection fraction (HFpEF). It has also demonstrated renal benefits by reducing urine albumin-to-creatinine ratio in patients with type 2 diabetes.

If you have any specific questions or want to know more about the benefits and limitations of tirzepatide, feel free to ask!I